FDA22 Jan 2021 21:40
Are we waiting for key staffers to be in place.
FDA
Biden hasn't yet announced a nominee for FDA commissioner, another position that requires Senate confirmation. Until a permanent commissioner is confirmed, Janet Wood****, the longtime director of FDA's Center for Drug Evaluation and Research, will serve as the agency's acting commissioner, Biden's administration announced this week.
While serving as acting commissioner, Wood**** also will continue serving in her role as the therapeutics lead for Operation Warp Speed, a federal initiative launched by the Trump administration to develop and distribute Covid-19 vaccines. As such, Wood**** will continue to recuse herself from making decisions on Covid-19 therapeutics at FDA, as well as from making decisions on matters relating to some specific companies involved in the Operation Warp Speed effort. "To help with the transition, I've been asked to continue some work with the therapeutics development effort. This work will involve government-sponsored research and clinical trials, and other matters that would be appropriate for an FDA employee. I will not be involved in contract discussions or similar matters with individual companies," Wood**** wrote in an email sent Wednesday to FDA staff.
https://www.advisory.com/daily-briefing/2021/01/22/biden-leaders